(NASDAQ: GBIO) Generation Bio Co's forecast annual revenue growth rate of 4.84% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.95%.
Generation Bio Co's revenue in 2024 is $9,963,000.On average, 3 Wall Street analysts forecast GBIO's revenue for 2024 to be $689,238,782, with the lowest GBIO revenue forecast at $272,768,244, and the highest GBIO revenue forecast at $935,395,490. On average, 2 Wall Street analysts forecast GBIO's revenue for 2025 to be $716,848,251, with the lowest GBIO revenue forecast at $404,495,347, and the highest GBIO revenue forecast at $1,029,201,155.
In 2026, GBIO is forecast to generate $768,075,458 in revenue, with the lowest revenue forecast at $404,495,347 and the highest revenue forecast at $1,131,655,568.